
    
      Randomized clinical trial in the Logo health zone, in Ituri province, Democratic Republic of
      Congo to compare seizure freedom in onchocerciasis infested epilepsy patients who ivermectin
      treatment once a year compared to 2 and 3 times a year. All participants also receive
      anti-epileptic drugs according to local guidelines for epilepsy treatment. Participants will
      be followed for 12 months.The primary endpoint is seizure freedom defined as no seizures
      during the last fourth months of the trial.
    
  